10-Q: Quarterly report
8-K: BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates
SCHEDULE 13G: Others
SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AMR Action Fund, L.P.(4.9%),AMR Action Fund GP, LLC(4.9%), etc.
SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-John H. Burbank III(2.9%),Nimble Ventures, LLC(2.9%)
15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Rodney Hodges(3.1%),POD Sàrl(3.1%), etc.
25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
8-K: Current report
8-K: Current report
4: Statement of changes in beneficial ownership of securities-Officer Bassan Merav
4: Statement of changes in beneficial ownership of securities-Officer Solomon Jonathan Eitan
4: Statement of changes in beneficial ownership of securities-Officer Oron Assaf
S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
8-K: Current report
10-Q: Q2 2024 Earnings Report
8-K: Current report
SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-OrbiMed Israel GP Ltd.(9.99%),OrbiMed Israel BioFund GP Limited Partnership(9.99%), etc.
4: Statement of changes in beneficial ownership of securities-Director Flynn James E
424B3: Prospectus
No Data
No Data